G Protein-Coupled Receptors, Part B: Volume 149

ISBN-13: 9780128151075 / Angielski / Twarda / 2019 / 332 str.

Arun K. Shukla

Spis treści

1. Optical approaches for visualization of arrestin binding to muscarinic receptor Seung Ryoung Jung 2. Luciferase Reporter Assay for Unlocking Ligand-mediated Signaling of GPCRs Hamiyet Unal 3. Assays to measure GPCR dependent cellular migration Carole A. Parent 4. Characterization of the Frizzled GPCRs Vladimir L. Katanaev 5. Binding assays for bradykinin and angiotensin receptors Renan Martin 6. Detection of misfolded rhodopsin aggregates in cells Paul Park 7. Measuring GPCR ubiquitination and trafficking Samarjit Bhattacharyya 8. Culture of primary neurons and its use in studying GPCR trafficking Prem N. Yadav 9. ELISA based assay for measuring agonist-induced GPCR endocytosis Arun K. Shukla 10. Western blot assay for measuring agonist-induced ERK1/2 phosphorylation Arun K. Shukla 11. Understanding GPCR dimerization Agata Faron-Górecka 12. Investigating the Frizzled family of receptors Vladimir L. Katanaev 13. Measuring GPCR signaling through xCELLigence system based assay Laura Heitman 14. Novel mechanisms of GPCR signaling and bias Gabriel Carmona Rosas 15. co-IP assays to measure GPCR-arrestin interactions Anastasios Lymperopoulos 16. Investigating arrestin dependent GPCR signaling Sadashiva Karnik 17. Measuring CRH1 receptor signaling Susana Silberstein 18. Site-specific side chain labeling for NMR studies of G protein-coupled receptors Brian F. Volkman 19. Modeling chemokine receptors and their orthosteric site interactions Brian F. Volkman 20. Receptor-channel cross-talk Uri Kahanovitch 21. Wnt receptor signaling Nibaldo C. Inestrosa

O autorze

Dr. Arun K. Shukla is a world leader in the field of GPCR biology and he is currently a Professor in the Department of Biological Sciences and Bioengineering at the Institute of Technology, Kanpur in India. Dr. Shukla's research program is focused on understanding the structure, function and regulation of G protein-coupled receptors with a long-term of designing novel therapeutics with minimized side-effects.